Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01707004
Title Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide

Decitabine

Filgrastim

Fludarabine

Busulfan

Age Groups: adult
Covered Countries USA


No variant requirements are available.